<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36315558</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>10</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Metabolic disorders and post-acute hospitalization in black/mixed-race patients with long COVID in Brazil: A cross-sectional analysis.</ArticleTitle><Pagination><StartPage>e0276771</StartPage><MedlinePgn>e0276771</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0276771</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0276771</ELocationID><Abstract><AbstractText Label="BACKGROUND">Although low-middle income countries have been disproportionately affected by the COVID-19 pandemic, there is scarce information about the impact of long COVID on their population. This study aimed to evaluate long COVID symptomatology, complications (hospital readmission and metabolic disorders), and main clinical features that impact Quality of Life (QoL).</AbstractText><AbstractText Label="METHODS">This cross-sectional study provides a detailed clinical and laboratory picture of individuals who presented residual symptoms after mild to severe acute COVID-19. Between Aug-2020 to Sep-2021, long COVID patients were evaluated in a reference center for long COVID in Bahia State, Brazil. The EQ-5D-5L questionnaire accessed QoL.</AbstractText><AbstractText Label="RESULTS">A total of 1164 (52 &#xb1;13.4 years, 57% female, 88% black/mixed-race) were evaluated 2.3 [IQR = 1.6-3.7] months after mild (n = 351, 30.2%), moderate (338, 29.0%) or severe (475, 40.8%) acute illness. Dyspnea (790, 67.9%), fatigue (738, 63.5%), and chest pain (525, 42.9%) were the most frequent residual symptoms regardless of acute severity, affecting the QoL of 88.9% of patients (n/N-826/925), mainly the domains of anxiety/depression and pain/discomfort. High levels of HbA1c were detected for 175 out of 664 patients (26.6%), 40% of them without a previous diagnosis of diabetes mellitus. Of note, hospital admission one-to-three months after the acute phase of disease was required for 51 (4.4%) patients.</AbstractText><AbstractText Label="CONCLUSION">In this majority-black/mixed-race population, long COVID was associated with post-acute hospitalization, newly diagnosed diabetes mellitus, and decreased QoL, particularly in women and regardless of disease severity of acute infection, suggesting important implications for health care system.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barreto</LastName><ForeName>Ana Paula Andrade</ForeName><Initials>APA</Initials><AffiliationInfo><Affiliation>Hospital Especializado Oct&#xe1;vio Mangabeira (HEOM), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Escola Bahiana de Medicina e Sa&#xfa;de P&#xfa;blica (EBMSP), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barreto Filho</LastName><ForeName>Marcio Andrade</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-1669-3599</Identifier><AffiliationInfo><Affiliation>Hospital Especializado Oct&#xe1;vio Mangabeira (HEOM), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Escola Bahiana de Medicina e Sa&#xfa;de P&#xfa;blica (EBMSP), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>Lucimeire Cardoso</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Hospital Especializado Oct&#xe1;vio Mangabeira (HEOM), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Escola Bahiana de Medicina e Sa&#xfa;de P&#xfa;blica (EBMSP), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerqueira-Silva</LastName><ForeName>Thiago</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-4534-2509</Identifier><AffiliationInfo><Affiliation>Instituto Gon&#xe7;alo Moniz (Fiocruz-Bahia), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal da Bahia (UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camelier</LastName><ForeName>Aquiles</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Especializado Oct&#xe1;vio Mangabeira (HEOM), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Funda&#xe7;&#xe3;o Maria Em&#xed;lia Freire de Carvalho (FME), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavares</LastName><ForeName>Natalia Machado</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Instituto Gon&#xe7;alo Moniz (Fiocruz-Bahia), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barral-Netto</LastName><ForeName>Manoel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Instituto Gon&#xe7;alo Moniz (Fiocruz-Bahia), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal da Bahia (UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boaventura</LastName><ForeName>Viviane</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-7241-6844</Identifier><AffiliationInfo><Affiliation>Instituto Gon&#xe7;alo Moniz (Fiocruz-Bahia), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal da Bahia (UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Marcelo Chalhoub Coelho</ForeName><Initials>MCC</Initials><AffiliationInfo><Affiliation>Hospital Especializado Oct&#xe1;vio Mangabeira (HEOM), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Salvador, (UNIFACS), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CPC study group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008659" MajorTopicYN="Y">Metabolic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>31</Day><Hour>13</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36315558</ArticleId><ArticleId IdType="pmc">PMC9621406</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0276771</ArticleId><ArticleId IdType="pii">PONE-D-22-10158</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 United States Cases by County. Available: https://coronavirus.jhu.edu/map.html</Citation></Reference><Reference><Citation>Datta SD, Talwar A, Lee JT. A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection. JAMA. 2020;324: 2251. doi: 10.1001/jama.2020.22717</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Norton A, Olliaro P, Sigfrid L, Carson G, Paparella G, Hastie C, et al.. Long COVID: tackling a multifaceted condition requires a multidisciplinary approach. Lancet Infect Dis. 2021;21: 601&#x2013;602. doi: 10.1016/S1473-3099(21)00043-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00043-8</ArticleId><ArticleId IdType="pmc">PMC7906694</ArticleId><ArticleId IdType="pubmed">33548193</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, et al.. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw Open. 2021;4: e210830&#x2013;e210830. doi: 10.1001/jamanetworkopen.2021.0830</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbeis F, Thibeault C, Doellinger F, Ring RM, Mittermaier M, Ruwwe-Gl&#xf6;senkamp C, et al.. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months. Respir Med. 2022;191: 106709. doi: 10.1016/j.rmed.2021.106709</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106709</ArticleId><ArticleId IdType="pmc">PMC8632363</ArticleId><ArticleId IdType="pubmed">34871947</ArticleId></ArticleIdList></Reference><Reference><Citation>Yomogida K, Zhu S, Rubino F, Figueroa W, Balanji N, Holman E. Post-Acute Sequelae of SARS-CoV-2 Infection Among Adults Aged &#x2265;18 Years&#x2014;Long Beach, California, April 1&#x2013;December 10, 2020. MMWR Morb Mortal Wkly Rep. 2021;70: 1274&#x2013;1277. doi: 10.15585/mmwr.mm7037a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7037a2</ArticleId><ArticleId IdType="pmc">PMC8445372</ArticleId><ArticleId IdType="pubmed">34529639</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al.. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397: 220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324: 603. doi: 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al.. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11: e048391. doi: 10.1136/bmjopen-2020-048391</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health England. Disparities in the risk and outcomes of About Public Health England. 2020; 89. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/908434/Disparities_in_the_risk_and_outcomes_of_COVID_August_2020_update.pdf</Citation></Reference><Reference><Citation>Ranzani OT, Bastos LSL, Gelli JGM, Marchesi JF, Bai&#xe3;o F, Hamacher S, et al.. Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med. 2021;9: 407&#x2013;418. doi: 10.1016/S2213-2600(20)30560-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30560-9</ArticleId><ArticleId IdType="pmc">PMC7834889</ArticleId><ArticleId IdType="pubmed">33460571</ArticleId></ArticleIdList></Reference><Reference><Citation>Titze-de-Almeida R, da Cunha TR, dos Santos Silva LD, Ferreira CS, Silva CP, Ribeiro AP, et al.. Persistent, new-onset symptoms and mental health complaints in Long COVID in a Brazilian cohort of non-hospitalized patients. BMC Infect Dis. 2022;22: 133. doi: 10.1186/s12879-022-07065-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07065-3</ArticleId><ArticleId IdType="pmc">PMC8821794</ArticleId><ArticleId IdType="pubmed">35135496</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonif&#xe1;cio LP, Csizmar VNF, Barbosa-J&#xfa;nior F, Pereira APS, Koenigkam-Santos M, Wada DT, et al.. Long-Term Symptoms among COVID-19 Survivors in Prospective Cohort Study, Brazil. Emerg Infect Dis. 2022;28: 730&#x2013;733. doi: 10.3201/eid2803.212020</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2803.212020</ArticleId><ArticleId IdType="pmc">PMC8888217</ArticleId><ArticleId IdType="pubmed">35133956</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)&#x2014;A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42: 377&#x2013;381. doi: 10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O&#x2019;Neal L, et al.. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95: 103208. doi: 10.1016/j.jbi.2019.103208</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovelis D, Segretti NO, Probst VS, Lareau SC, Brunetto AF, Pitta F. Valida&#xe7;&#xe3;o do Modified Pulmonary Functional Status and Dyspnea Questionnaire e da escala do Medical Research Council para o uso em pacientes com doen&#xe7;a pulmonar obstrutiva cr&#xf4;nica no Brasil. J Bras Pneumol. 2008;34: 1008&#x2013;1018. doi: 10.1590/S1806-37132008001200005</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1806-37132008001200005</ArticleId><ArticleId IdType="pubmed">19180335</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al.. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20: 1727&#x2013;1736. doi: 10.1007/s11136-011-9903-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: A language and environment for statistical computing. 2021.  [cited 1 Jun 2021]. Available: https://www.r-project.org/</Citation></Reference><Reference><Citation>Brant R. Assessing Proportionality in the Proportional Odds Model for Ordinal Logistic Regression. Biometrics. 1990;46: 1171. doi: 10.2307/2532457</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2532457</ArticleId><ArticleId IdType="pubmed">2085632</ArticleId></ArticleIdList></Reference><Reference><Citation>LaVergne SM, Stromberg S, Baxter BA, Webb TL, Dutt TS, Berry K, et al.. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. BMC Infect Dis. 2021;21: 677. doi: 10.1186/s12879-021-06359-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06359-2</ArticleId><ArticleId IdType="pmc">PMC8276222</ArticleId><ArticleId IdType="pubmed">34256735</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al.. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection. JAMA Netw Open. 2021;4: e2128568. doi: 10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al.. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021; n693. doi: 10.1136/bmj.n693</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Tapp RJ, Cooper ME, Zimmet P. Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. Diabetes Metab. 2020/10/28. 2021;47: 101204. doi: 10.1016/j.diabet.2020.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabet.2020.10.002</ArticleId><ArticleId IdType="pmc">PMC7591867</ArticleId><ArticleId IdType="pubmed">33129968</ArticleId></ArticleIdList></Reference><Reference><Citation>GALLAGHER EJ, ROITH D, BLOOMGARDEN Z. Review of hemoglobin A1c in the management of diabetes. J Diabetes. 2009;1: 9&#x2013;17. doi: 10.1111/j.1753-0407.2009.00009.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1753-0407.2009.00009.x</ArticleId><ArticleId IdType="pubmed">20923515</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavagnolli G, Pimentel AL, Freitas PAC, Gross JL, Camargo JL. Effect of ethnicity on HbA1c levels in individuals without diabetes: Systematic review and meta-analysis. Ali R, editor. PLoS One. 2017;12: e0171315. doi: 10.1371/journal.pone.0171315</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0171315</ArticleId><ArticleId IdType="pmc">PMC5305058</ArticleId><ArticleId IdType="pubmed">28192447</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaskaran K, Rentsch CT, Hickman G, Hulme WJ, Schultze A, Curtis HJ, et al.. Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform. Basu S, editor. PLOS Med. 2022;19: e1003871. doi: 10.1371/journal.pmed.1003871</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003871</ArticleId><ArticleId IdType="pmc">PMC8789178</ArticleId><ArticleId IdType="pubmed">35077449</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly JP, Wang XQ, Iwashyna TJ, Prescott HC. Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System. JAMA. 2021;325: 304&#x2013;306. doi: 10.1001/jama.2020.21465</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.21465</ArticleId><ArticleId IdType="pmc">PMC7737131</ArticleId><ArticleId IdType="pubmed">33315057</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbari A, Fathabadi A, Razmi M, Zarifian A, Amiri M, Ghodsi A, et al.. Characteristics, risk factors, and outcomes associated with readmission in COVID-19 patients: A systematic review and meta-analysis. Am J Emerg Med. 2022;52: 166&#x2013;173. doi: 10.1016/j.ajem.2021.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2021.12.012</ArticleId><ArticleId IdType="pmc">PMC8665665</ArticleId><ArticleId IdType="pubmed">34923196</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen LO, Young RS, Hinami K, Leung A, Williams M V. Interventions to Reduce 30-Day Rehospitalization: A Systematic Review. Ann Intern Med. 2011;155: 520. doi: 10.7326/0003-4819-155-8-201110180-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-155-8-201110180-00008</ArticleId><ArticleId IdType="pubmed">22007045</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutinho WF, Silva J&#xfa;nior WS. Diabetes Care in Brazil. Ann Glob Heal. 2015;81: 735&#x2013;741. doi: 10.1016/j.aogh.2015.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aogh.2015.12.010</ArticleId><ArticleId IdType="pubmed">27108141</ArticleId></ArticleIdList></Reference><Reference><Citation>dos Santos ESM, M&#xe1;ximo R de O, de Andrade FB, de Oliveira C, Lima-Costa MF, Alexandre T da S. Differences in the prevalence of prediabetes, undiagnosed diabetes and diagnosed diabetes and associated factors in cohorts of Brazilian and English older adults. Public Health Nutr. 2021;24: 4187&#x2013;4194. doi: 10.1017/S1368980020003201</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1368980020003201</ArticleId><ArticleId IdType="pmc">PMC9014254</ArticleId><ArticleId IdType="pubmed">32972476</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu G, Zhen Q, Wang W, Fan S, Wu Q, Zhang C, et al.. Health&#x2010;related quality of life of COVID&#x2010;19 patients after discharge: A multicenter follow&#x2010;up study. J Clin Nurs. 2021;30: 1742&#x2013;1750. doi: 10.1111/jocn.15733</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.15733</ArticleId><ArticleId IdType="pmc">PMC8013595</ArticleId><ArticleId IdType="pubmed">33656210</ArticleId></ArticleIdList></Reference><Reference><Citation>Vadivelu N, Kai AM, Kodumudi G, Babayan K, Fontes M, Burg MM. Pain and Psychology-A Reciprocal Relationship. Ochsner J. 2017;17: 173&#x2013;180. doi: 28638291
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5472077</ArticleId><ArticleId IdType="pubmed">28638291</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladwig KH, Marten-Mittag B, Formanek B, Dammann G. Gender differences of symptom reporting and medical health care utilization in the German population. Eur J Epidemiol. 2000;16: 511&#x2013;8. doi: 10.1023/a:1007629920752</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1007629920752</ArticleId><ArticleId IdType="pubmed">11049093</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al.. Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin Infect Dis. 2021. doi: 10.1093/cid/ciab611</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanhorebeek I, Latronico N, Van den Berghe G. ICU-acquired weakness. Intensive Care Med. 2020;46: 637&#x2013;653. doi: 10.1007/s00134-020-05944-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05944-4</ArticleId><ArticleId IdType="pmc">PMC7224132</ArticleId><ArticleId IdType="pubmed">32076765</ArticleId></ArticleIdList></Reference><Reference><Citation>Schakman O, Kalista S, Barb&#xe9; C, Loumaye A, Thissen JP. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol. 2013;45: 2163&#x2013;2172. doi: 10.1016/j.biocel.2013.05.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2013.05.036</ArticleId><ArticleId IdType="pubmed">23806868</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022. doi: 10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>